Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Nidhya Navanandan

Concepts (108)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Asthma
16
2025
1800
4.380
Why?
Anti-Asthmatic Agents
5
2024
263
1.840
Why?
Oscillometry
2
2025
35
1.530
Why?
Adrenal Cortex Hormones
6
2025
486
1.380
Why?
Emergency Service, Hospital
14
2025
2363
1.330
Why?
Pneumonia
7
2023
635
1.230
Why?
Bronchodilator Agents
4
2025
186
1.190
Why?
Respiratory Sounds
2
2024
102
0.970
Why?
Respiratory Tract Infections
4
2024
403
0.950
Why?
Airway Resistance
2
2025
38
0.860
Why?
Severity of Illness Index
5
2025
2921
0.800
Why?
Community-Acquired Infections
5
2023
179
0.790
Why?
Recurrence
2
2024
1133
0.790
Why?
Child
28
2025
22693
0.790
Why?
Virus Diseases
2
2023
219
0.720
Why?
Child, Preschool
15
2025
11913
0.610
Why?
Medicaid
1
2024
477
0.590
Why?
Staphylococcus aureus
1
2023
459
0.580
Why?
Glucocorticoids
2
2020
536
0.540
Why?
Physicians, Primary Care
1
2020
210
0.510
Why?
Patient Discharge Summaries
1
2017
10
0.500
Why?
Dexamethasone
4
2025
368
0.480
Why?
Biomedical Research
1
2023
729
0.480
Why?
Pulmonary Embolism
1
2019
246
0.470
Why?
Positive-Pressure Respiration
1
2017
115
0.470
Why?
Prospective Studies
11
2025
8123
0.450
Why?
Health Literacy
1
2017
183
0.420
Why?
Prednisone
3
2020
229
0.400
Why?
Emergency Medical Services
2
2021
680
0.400
Why?
Physicians
1
2022
955
0.390
Why?
Humans
30
2025
146342
0.360
Why?
Acute Disease
4
2024
1038
0.350
Why?
Patient Readmission
1
2017
778
0.330
Why?
Prednisolone
2
2020
65
0.310
Why?
Male
16
2025
73396
0.280
Why?
Caregivers
1
2017
1080
0.260
Why?
ROC Curve
2
2025
617
0.240
Why?
Patient Discharge
3
2024
997
0.230
Why?
Female
14
2025
79499
0.220
Why?
Disease Progression
2
2024
2867
0.220
Why?
Infant
7
2024
10114
0.210
Why?
Rhinovirus
1
2024
60
0.210
Why?
Hospitalization
4
2022
2475
0.210
Why?
Adolescent
7
2025
22557
0.200
Why?
Picornaviridae Infections
1
2024
53
0.200
Why?
Risk Factors
4
2024
10921
0.200
Why?
Respiratory Function Tests
1
2025
543
0.200
Why?
Enterotoxins
1
2023
89
0.200
Why?
Quality of Life
4
2024
3200
0.190
Why?
Bronchiolitis
1
2024
88
0.190
Why?
Respiratory Syncytial Virus, Human
1
2023
83
0.180
Why?
Albuterol
2
2025
76
0.180
Why?
Educational Status
1
2024
466
0.170
Why?
Magnesium
1
2022
155
0.170
Why?
Respiratory Syncytial Virus Infections
1
2023
141
0.170
Why?
Administration, Intravenous
1
2022
172
0.170
Why?
Viruses
1
2023
165
0.160
Why?
Delphi Technique
1
2023
350
0.160
Why?
Dyspnea
1
2023
251
0.160
Why?
Schools
1
2024
436
0.160
Why?
Consensus
1
2023
467
0.160
Why?
Allergens
1
2023
390
0.160
Why?
Drug Monitoring
1
2024
399
0.150
Why?
Surveys and Questionnaires
2
2023
6073
0.150
Why?
Thrombectomy
1
2019
79
0.140
Why?
Vena Cava Filters
1
2019
68
0.130
Why?
Self Report
1
2022
870
0.130
Why?
Administration, Oral
1
2020
872
0.130
Why?
Ipratropium
1
2017
4
0.130
Why?
Retrospective Studies
4
2025
17438
0.130
Why?
Infant, Newborn
3
2024
6460
0.130
Why?
Influenza, Human
1
2023
640
0.120
Why?
Nebulizers and Vaporizers
1
2017
63
0.120
Why?
Single-Blind Method
1
2017
313
0.120
Why?
Sepsis
1
2022
669
0.110
Why?
Tertiary Care Centers
1
2017
196
0.110
Why?
Feasibility Studies
1
2020
1135
0.110
Why?
Phenotype
1
2023
3206
0.110
Why?
Health Surveys
1
2017
511
0.110
Why?
Prognosis
1
2023
4351
0.100
Why?
Combined Modality Therapy
1
2017
1271
0.100
Why?
Anticoagulants
1
2019
746
0.100
Why?
Patient Satisfaction
1
2017
706
0.090
Why?
Treatment Outcome
2
2024
11821
0.090
Why?
United States
3
2025
16136
0.090
Why?
Ambulatory Care
1
2017
628
0.090
Why?
Biomarkers
1
2023
4340
0.090
Why?
Primary Health Care
1
2020
1776
0.080
Why?
Pediatrics
1
2017
1124
0.070
Why?
Health Knowledge, Attitudes, Practice
1
2017
1408
0.070
Why?
Adult
2
2020
41087
0.050
Why?
Uncertainty
1
2024
145
0.050
Why?
Treatment Failure
1
2024
361
0.050
Why?
Patient Acuity
1
2022
46
0.050
Why?
Anti-Bacterial Agents
2
2022
1942
0.040
Why?
Fever
1
2022
322
0.040
Why?
Aftercare
1
2022
225
0.040
Why?
Epinephrine
1
2021
160
0.040
Why?
Young Adult
1
2017
14330
0.040
Why?
Fatigue
1
2022
363
0.040
Why?
Odds Ratio
1
2022
1077
0.040
Why?
Hospitals, Pediatric
1
2022
561
0.030
Why?
Middle Aged
1
2020
36619
0.030
Why?
Tomography, X-Ray Computed
1
2024
2786
0.020
Why?
Follow-Up Studies
1
2022
5439
0.020
Why?
Cohort Studies
1
2022
6077
0.020
Why?
Lung
1
2024
4122
0.020
Why?
Cross-Sectional Studies
1
2022
5899
0.020
Why?
Navanandan's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description
Physical Neighbors Expand Description
_

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)